T M L Tong

5PUBLICATIONS
0CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Medical parasitologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 06, 2024
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

T M L Tong, M Fiocco, J J van Duijn-de Vreugd

|Apr 08, 2024
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

T M L Tong, M Fiocco, J J van Duijn-de Vreugd

|Jan 09, 2023
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.

T M L Tong, M C Burgmans, F M Speetjens

|Aug 03, 2022
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.

T M L Tong, M Samim, E Kapiteijn

|Feb 14, 2022
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.

T M L Tong, M K van der Kooij, F M Speetjens

Pageof 1

Frequent Collaborators